Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email greg.mullins@researchaustralia.org.

Please click the heading in the left hand column to access consultation information from the relevant website.

Consultation

Details

Automated Decision making and AI Regulation

 

Due 20 May (extended)

 The Australian Government is consulting on how it should regulate Automated Decision Making and Artificial Intelligence. There are growing applications for both ADM and AI in healthcare, and regulation could potentially have implications for research in this area.

The Department of Prime Minister and Cabinet is seeking submissions on an Issues Paper.

Research Block Grant Reforms to promote industry collaboration

 

Due 31 May

 The Department of Education is seeking views on proposed reform to the research block grant (RBG) funding framework to boost greater collaboration between universities and industry.

The objective for the proposed change and implementation approach are set out in a consultation paper, with discussion questions to guide submissions.

A National Accreditation Scheme for National Mutual Acceptance HRECs

 

 

 

 Australian governments are collaborating to streamline clinical trial and research approval processes.

Promoting mutual acceptance of ethical review remains a key priority, and all jurisdictions have agreed to transition to a revised and expanded National Mutual Acceptance (NMA) scheme, based on accreditation of ethics committees to a national quality standard to be developed by the Australian Commission on Safety and Quality in Health Care (the Commission) with oversight by the Clinical Trials Project Reference Group (CTPRG).

A primary focus will be safety and quality, seeking to distinguish and leverage Australia’s competitive advantage and reputation for quality.

Register your interest now to get updates on the upcoming consultations on the accreditation standard and how you can be involved.